26378384|t|Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy.
26378384|a|OBJECTIVES: Decreased magnetization transfer ratio (MTR) in the brain characterizes cerebral edema (CE) in patients with liver cirrhosis, but the role of treatment on its reversibility has not been studied in patients who have minimal hepatic encephalopathy (MHE). This study was carried to evaluate the reversibility of CE with lactulose and rifaximin treatment in patients with MHE and role of ammonia, pro-inflammatory interleukins (IL-1, IL-6) and tumor necrosis factor (TNF)-alpha in its pathogenesis. METHODS: Twenty-three patients with cirrhosis (14 with MHE, 9 without MHE (NMHE)) and 6 healthy controls underwent ammonia, IL-1, IL-6, TNF-alpha estimation, and MTR in frontal white matter (FWM), parietal white matter (PWM), internal capsule (IC), and basal ganglia (BG). RESULTS: Ammonia was significantly higher in the cirrhosis group compared with controls and in MHE compared with the NMHE group. Ammonia correlated positively with IL-1 and IL-6. MTRs in FWM, PWM, IC, and BG were significantly lower in the MHE group compared with controls and in PWM, IC, and BG compared with the NMHE group. MHE patients showed significant MTR increase in FWM, PWM, and IC with treatment. IL-6 and ammonia had significant negative and significant positive psychometric hepatic encephalopathy score (PHES) correlation with MTR in various regions. CONCLUSIONS: This study, for the first time, demonstrated the reversibility of low-grade CE with treatment in patients with MHE. Negative correlation between ammonia, IL-6 levels, and MTR and positive correlation between PHES and MTR in MHE patients suggests the role of inflammation and ammonia in the genesis of low-grade CE.
26378384	22	36	Cerebral Edema	Disease	MESH:D001929
26378384	43	52	Lactulose	Chemical	MESH:D007792
26378384	53	62	Rifaximin	Chemical	MESH:D000078262
26378384	74	82	Patients	Species	9606
26378384	88	97	Cirrhosis	Disease	MESH:D005355
26378384	110	132	Hepatic Encephalopathy	Disease	MESH:D006501
26378384	218	232	cerebral edema	Disease	MESH:D001929
26378384	234	236	CE	Disease	MESH:D001929
26378384	241	249	patients	Species	9606
26378384	255	270	liver cirrhosis	Disease	MESH:D008103
26378384	343	351	patients	Species	9606
26378384	369	391	hepatic encephalopathy	Disease	MESH:D006501
26378384	393	396	MHE	Disease	MESH:D006501
26378384	455	457	CE	Disease	MESH:D001929
26378384	463	472	lactulose	Chemical	MESH:D007792
26378384	477	486	rifaximin	Chemical	MESH:D000078262
26378384	500	508	patients	Species	9606
26378384	514	517	MHE	Disease	MESH:D006501
26378384	530	537	ammonia	Chemical	MESH:D000641
26378384	543	555	inflammatory	Disease	MESH:D007249
26378384	570	574	IL-1	Gene	3552
26378384	576	580	IL-6	Gene	3569
26378384	586	619	tumor necrosis factor (TNF)-alpha	Gene	7124
26378384	663	671	patients	Species	9606
26378384	677	686	cirrhosis	Disease	MESH:D005355
26378384	696	699	MHE	Disease	MESH:D006501
26378384	711	714	MHE	Disease	MESH:D006501
26378384	716	720	NMHE	Disease	
26378384	756	763	ammonia	Chemical	MESH:D000641
26378384	765	769	IL-1	Gene	3552
26378384	771	775	IL-6	Gene	3569
26378384	777	786	TNF-alpha	Gene	7124
26378384	923	930	Ammonia	Chemical	MESH:D000641
26378384	963	972	cirrhosis	Disease	MESH:D005355
26378384	1009	1012	MHE	Disease	MESH:D006501
26378384	1031	1035	NMHE	Disease	
26378384	1043	1050	Ammonia	Chemical	MESH:D000641
26378384	1078	1082	IL-1	Gene	3552
26378384	1087	1091	IL-6	Gene	3569
26378384	1154	1157	MHE	Disease	MESH:D006501
26378384	1228	1232	NMHE	Disease	
26378384	1240	1243	MHE	Disease	MESH:D006501
26378384	1244	1252	patients	Species	9606
26378384	1321	1325	IL-6	Gene	3569
26378384	1330	1337	ammonia	Chemical	MESH:D000641
26378384	1401	1423	hepatic encephalopathy	Disease	MESH:D006501
26378384	1567	1569	CE	Disease	MESH:D001929
26378384	1588	1596	patients	Species	9606
26378384	1602	1605	MHE	Disease	MESH:D006501
26378384	1636	1643	ammonia	Chemical	MESH:D000641
26378384	1645	1649	IL-6	Gene	3569
26378384	1715	1718	MHE	Disease	MESH:D006501
26378384	1719	1727	patients	Species	9606
26378384	1749	1761	inflammation	Disease	MESH:D007249
26378384	1766	1773	ammonia	Chemical	MESH:D000641
26378384	1802	1804	CE	Disease	MESH:D001929
26378384	Association	MESH:D000641	3552
26378384	Association	MESH:D006501	3569
26378384	Negative_Correlation	MESH:D007792	MESH:D001929
26378384	Association	MESH:D000641	3569
26378384	Positive_Correlation	MESH:D000641	MESH:D006501
26378384	Comparison	MESH:D000078262	MESH:D007792
26378384	Negative_Correlation	MESH:D000078262	MESH:D006501
26378384	Negative_Correlation	MESH:D000078262	MESH:D005355
26378384	Negative_Correlation	MESH:D007792	MESH:D005355
26378384	Negative_Correlation	MESH:D007792	MESH:D006501
26378384	Negative_Correlation	MESH:D000078262	MESH:D001929
26378384	Positive_Correlation	MESH:D000641	MESH:D005355

